Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 298, Issue 4, 2010, Pages

  Ramchandra, Rohit ^a   Watson, Anna M D ^a,b   Hood, Sally G ^a   May, Clive N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Angiotensin receptor blockade; Baroreflex

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; IRBESARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DRUG INFUSION; FEMALE; HEART; HEART BEAT; HEART FAILURE; HEART RATE; HEART VENTRICLE PACING; NERVE CONDUCTION; NONHUMAN; OUTCOME ASSESSMENT; PRESSOR RESPONSE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REST; SHEEP; SYMPATHETIC NERVE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BAROREFLEX; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CAROTID ARTERIES; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART FAILURE; HEART RATE; SHEEP; SYMPATHETIC NERVOUS SYSTEM; TETRAZOLES; VENTRICULAR FUNCTION, LEFT;

EID: 77949783905     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00767.2009     Document Type: Article

References (36)

1. Anonymous. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) The CONSENSUS Trial Study Group. N Engl J Med 316: 1429-1435, 1987.
2. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 22: 1136-1143, 2001.
3. Brunner-La Rocca HP, Vaddadi G, Esler MD. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism. J Am Coll Cardiol 33: 1163-1173, 1999.
4. Culman J, von Heyer C, Piepenburg B, Rascher W, Unger T. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats. Eur J Pharmacol 367: 255-265, 1999.
5. De Tommasi E, Iacoviello M, Romito R, Ceconi C, Guida P, Massari F, Francolini G, Bertocchi F, Ferrari R, Rizzon P, Pitzalis MV. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. Am Heart J 146: E17, 2003.
6. Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 27: 358-364, 1996.
7. DiBona GF, Sawin LL. Reflex regulation of renal nerve activity in cardiac failure. Am J Physiol Regul Integr Comp Physiol 266: R27-R39, 1994.
8. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285: 877-883, 1971.
9. Esler M. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function. J Hypertens Suppl 20: S13-S19, 2002.
10. Ferguson DW, Berg WJ, Roach PJ, Oren RM, Mark AL. Effects of heart failure on baroreflex control of sympathetic neural activity. Am J Cardiol 69: 523-531, 1992.
11. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273: 1450-1456, 1995.
12. Gohlke P, Kox T, Jurgensen T, von Kugelgen S, Rascher W, Unger T, Culman J. Peripherally applied candesartan inhibits central responses to angiotensin II in conscious rats. Naunyn Schmiedebergs Arch Pharmacol 365: 477-483, 2002.
13. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 96: 1173-1179, 1997.
14. Hikosaka M, Yuasa F, Yuyama R, Mimura J, Kawamura A, Motohiro M, Iwasaki M, Sugiura T, Iwasaka T. Candesartan and arterial baroreflex sensitivity and sympathetic nerve activity in patients with mild heart failure. J Cardiovasc Pharmacol 40: 875-880, 2002.
15. Johansson M, Rundqvist B, Petersson M, Lambert G, Friberg P. Regional norepinephrine spillover in response to angiotensin-converting enzyme inhibition in healthy subjects. J Hypertens 21: 1371-1375, 2003.
16. Kasama S, Toyama T, Hatori T, Sumino H, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M. Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure. Heart 92: 625-630, 2006.
17. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction. J Am Coll Cardiol 45: 661-667, 2005.
18. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M. Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril. Eur J Nucl Med Mol Imag 32: 964-971, 2005.
19. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26: 1257-1263, 1995.
20. Lumbers ER, McCloskey DI, Potter EK. Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol 294: 69-80, 1979.
21. Murakami H, Liu JL, Zucker IH. Angiotensin II blockade [corrected] enhances baroreflex control of sympathetic outflow in heart failure. Hypertension 29: 564-569, 1997.
22. Murakami H, Liu JL, Zucker IH. Blockade of AT1 receptors enhances baroreflex control of heart rate in conscious rabbits with heart failure. Am J Physiol Regul Integr Comp Physiol 271: R303-R309, 1996.
23. Noll G, Wenzel RR, de Marchi S, Shaw S, Luscher TF. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation 95: 2286-2292, 1997.
24. Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B. Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J 26: 906-913, 2005.
25. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. The SAVE Investigators. N Engl J Med 327: 669-677, 1992.
26. Polidori C, Ciccocioppo R, Nisato D, Cazaubon C, Massi M. Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment. Eur J Pharmacol 352: 15-21, 1998.
27. Ramchandra R, Hood SG, Denton DA, Woods RL, McKinley MJ, McAllen RM, May CN. Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure. Proc Natl Acad Sci USA 106: 924-928, 2009.
28. Ramchandra R, Hood SG, Watson AM, May CN. Responses of cardiac sympathetic nerve activity to changes in circulating volume differ in normal and heart failure sheep. Am J Physiol Regul Integr Comp Physiol 295: R719-R726, 2008.
29. Sundlof G, Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol 274: 621-637, 1978.
30. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med 38: 1085-1089, 1997.
31. 1 receptors in the nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 293: R2267-R2278, 2007.
32. Tsutamoto T, Tanaka T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, Nakae I, Ohnishi M, Wada A, Horie M. Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic peptide in patients with chronic heart failure: comparison with enalapril. Circ J 72: 740-746, 2008.
33. 1) receptor blockade on cardiac vagal control in heart failure. Clin Sci (Lond) 101: 559-566, 2001.
34. Watson AM, Hood SG, Ramchandra R, McAllen RM, May CN. Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex. Am J Physiol Heart Circ Physiol 293: H798-H804, 2007.
35. Watson AM, Mogulkoc R, McAllen RM, May CN. Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep. Am J Physiol Regul Integr Comp Physiol 286: R1051-R1056, 2004.
36. Zucker IH, Wang W. Reflex control of renal sympathetic nervous activity in heart failure. Herz 16: 82-91, 1991.